Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients
Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients
Recruiting · NCT06395285 · Registry updated 2026-06-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, cone-rod dystrophy, eye disorder, hereditary disease, inherited retinal dystrophy, macular degeneration, macular retinal edema, retinal degeneration, retinal disorder, retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome, uveal disorder, uveitis | Recruiting | Phase 1 | 2026-06-05 | NCT06395285 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm) | 2 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Duke Eye Center - Duke University Hospital | Durham | United States | 1 |
| John A. Moran Eye Center - University of Utah Health | Salt Lake City | United States | 1 |
| National Institutes of Health Clinical Center | Bethesda | United States | 800 |
| Peking Union Medical College Hospital | Beijing | China | 62 |
| Save Sight Institute - University of Sydney Eye Hospital | Sydney | Australia | 1 |